
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Overlap of esophageal disorders of gut-brain interactions (E-DGBIs) and GERD is highly prevalent in patients with refractory reflux symptoms</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Overlap of esophageal disorders of gut-brain interactions (E-DGBIs) and GERD is highly prevalent in patients with refractory reflux symptoms</strong></summary>
            <div>
                <ul><li>Authors: Federico Caldart, Charlotte Gabriel, Blandine Vauquelin, Pauline Rivière, Arthur Berger, Frank Zerbib</li><li>Journal: American Journal of Gastroenterology</li><li>Publication Date: Publish Ahead of Print, DOI: 10.14309/ajg.0000000000003542</li><li>Objective: Determine the prevalence and characteristics of confirmed refractory GERD and E-DGBIs in consecutive patients with refractory reflux symptoms.</li><li>Conclusion: E-DGBIs are highly prevalent in patients with proven GERD and refractory reflux symptoms.</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What percentage of patients with proven GERD and refractory symptoms have E-DGBI?</li><li>2. What are the two main categories of E-DGBI based on ambulatory pH/pH-impedance monitoring?</li><li>3. According to the Lyon 2.0 criteria, what AET threshold is considered pathological for GERD diagnosis off PPIs?</li><li>4. What percentage of patients with PPI-refractory reflux-like symptoms had a final diagnosis of refractory GERD in this study?</li><li>5. Name two non-esophageal DGBI conditions that are highly prevalent in patients with refractory reflux symptoms.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Key Definitions &amp; Concepts</strong></summary>
            <div>
                <ul><li>E-DGBIs: Esophageal disorders of gut-brain interaction.</li><li>GERD: Gastro-esophageal reflux disease.</li><li>PPIs: Proton pump inhibitors.</li><li>Refractory GERD: Persistent esophagitis/stricture or ongoing pathological reflux despite adequate PPI therapy.</li></ul>
                
        <details>
            <summary><strong>E-DGBI Subtypes</strong></summary>
            <div>
                <ul><li>Reflux Hypersensitivity (RH): Normal AET + positive symptom-reflux association.</li><li>Functional Heartburn (FH): Normal AET + no significant symptom-reflux correlation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Lyon Consensus 2.0</strong></summary>
            <div>
                <ul><li>GERD diagnosis requires troublesome symptoms + evidence of pathological reflux (endoscopy and/or ambulatory reflux monitoring).</li><li>AET &gt;6% is pathological off PPIs (wireless monitoring: AET &gt;6% for ≥2 days).</li><li>AET &gt;4% or &gt;80 reflux episodes on PPIs indicates refractory GERD.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Prevalence of E-DGBIs in Refractory GERD</strong></summary>
            <div>
                <ul><li>Study found &gt;70% of patients w/ proven GERD &amp; refractory symptoms despite PPIs have E-DGBI.</li><li>A previously confirmed GERD diagnosis off PPIs does not rule out FH or RH in patients on PPIs.</li></ul>
                
        <details>
            <summary><strong>Study Results</strong></summary>
            <div>
                <ul><li>Out of 46 proven GERD patients, 28% had isolated refractory GERD, 72% had overlap of GERD and E-DGBIs.</li><li>In unproven GERD group, 31.5% had GERD, 68.5% had an E-DGBI.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Implications</strong></summary>
            <div>
                <ul><li>E-DGBIs are the main cause of PPI failure in patients with proven GERD.</li><li>Highlights the limitation of symptom-based GERD diagnosis, especially when considering interventional treatment.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Patient Characteristics &amp; Comparisons</strong></summary>
            <div>
                <ul><li>E-DGBI patients w/ &amp; w/o GERD overlap have similar symptom load, non-esophageal DGBI, anxiety, &amp; depression scores.</li><li>No significant differences in gender or age between E-DGBI alone vs. E-DGBI-GERD overlap groups.</li></ul>
                
        <details>
            <summary><strong>Visceral Sensitivity</strong></summary>
            <div>
                <ul><li>Higher visceral sensitivity (VSI) observed in RH patients w/ GERD overlap (median 28.0) compared to RH-alone (median 18.0, p=0.033).</li><li>VSI score &gt;37.5 indicates increased visceral sensitivity.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Refractory GERD vs. Overlap</strong></summary>
            <div>
                <ul><li>Refractory GERD patients had higher AET (p=0.016), lower MNBI (p=0.006), &amp; more reflux episodes (p&lt;0.001) than GERD-E-DGBI overlap patients.</li><li>No significant differences in HADS &amp; VSI scores, nor in IBS &amp; FD prevalence between these groups.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Associated Conditions</strong></summary>
            <div>
                <ul><li>High prevalence of functional dyspepsia (FD) (70.6%) and irritable bowel syndrome (IBS) (33.6%) reported.</li><li>IBS and FD have been reported in several studies to be associated with PPI refractoriness.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Treatment Implications</strong></summary>
            <div>
                <ul><li>Only a minority of patients have actionable GERD &amp; may benefit from interventional management.</li><li>pH-impedance monitoring on PPIs may help select patients who could benefit from laparoscopic fundoplication.</li></ul>
                
        <details>
            <summary><strong>Future Research</strong></summary>
            <div>
                <ul><li>Studies w/ outcome data needed to determine if patients w/ overlapping E-DGBIs &amp; GERD should be identified w/ pH-impedance monitoring on PPI therapy before interventional treatment.</li><li>Future research should investigate long-term trajectories of GERD-E-DGBI overlap patients and evaluate responses to neuromodulators and dietary interventions.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
